Spectranetics (SPNC) Misses Q2 EPS by 27c, Beats on Revenues

Spectranetics (NASDAQ: SPNC) reported Q2 EPS of ($0.56), $0.27 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $74.7 million versus the consensus estimate of $73.82 million.

• Revenue of $74.7 million increased 10% (11% constant currency1)
• Vascular Intervention revenue of $51.0 million increased 10% (11% constant currency1)
• Lead Management revenue of $19.7 million increased 11% (12% constant currency1)

Net loss for the three months ended June 30, 2017 was $24.6 million, or $0.56 per share, compared with net loss of $14.9 million, or $0.35 per share, for the three months ended June 30, 2016.

For earnings history and earnings-related data on Spectranetics (SPNC) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
• Terra Innovatum Global N.V. (NKLR) Misses Q2 EPS by 12c